The client is a global leading pharmaceutical company specialized in developing and manufacturing new biologics, new chemical entities and innovative medicines. The client approached Freyr for Regulatory support for the new molecule committee (NMC) meeting with the COFEPRIS. The scope of the project included preparation and submission of pharmacovigilance to the Agency.
Download the case study to know how Freyr successfully completed the NMC meeting with the COFEPRIS and supported the client to register the product in Mexico.
